Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb randomized double-blind active-controlled trial of ACYW135 meningococcal conjugate vaccine in 2–3-year-old children
CTR20253639Phase 2Active
- Sponsor
- Sino Biopharmaceutical Limited
- Start
- Sep 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of meningococcal ACYW135 polysaccharide conjugate vaccine in meningitis, meningococcal disease, sponsored by Sino Biopharmaceutical Limited. Started Sep 2025; status: active.
02
Drugs
meningococcal ACYW135 polysaccharide conjugate vaccine
03
Conditions
meningitismeningococcal disease
Beyond the preview
Go deeper on CTR20253639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253639.